Article
Humoral immune response and immunoglobulin G Fc receptor genotype are associated with better clinical outcome following idiotype vaccination in follicular lymphoma patients regardless of their response to induction chemotherapy.
Blood - 1 Feb 2007
Weng Wen-Kai, Czerwinski Debra, Levy Ronald
Abstract excerpt
We have reported that anti-idiotype antibody response and FcgammaRIIIa 158 valine/valine (V/V) genotype both correlate with better outcome in a group of 136 follicular lymphoma patients receiving idiotype vaccination after induction chemotherapy. Here, we examined whether this correlation is related in any way to the chemotherapy response. In patients with complete response (CR), the 5-year progression-free...
Read the complete abstract on PubMedTopics
Share this publication in a Topic to start or enrich a Post.
